NCT05790876View on ClinicalTrials.gov

Super Saturated Oxygen (SSO2) Therapy in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Action on Coronary Microcirculation Dysfunction

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

March 7, 2025

Study Completion Date

June 11, 2025

Conditions
STEMICoronary Microvascular Dysfunction
Interventions
PROCEDURE

SSO2 therapy

SSO2 therapy consists of overoxygenating the patient's blood and delivering it to the origin of the LAD for 60 min. Improvement in CMD will be assessed by comparing angio-IMR before and after 60 minutes of SSO2 therapy measured on conventional angiographic images

Trial Locations (1)

38700

University Hospital Grenoble, La Tronche

All Listed Sponsors
collaborator

Zoll Medical Corporation

INDUSTRY

lead

University Hospital, Grenoble

OTHER